Proteins and nucleic acids encoding same

Details Proteins and nucleic acids encoding same Proteins and nucleic acids encoding same

2006-11-28

2006-11-28

Wax, Robert A. (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000

Reexamination Certificate

active

07141549

ABSTRACT:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4485045 (1984-11-01), Regen
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4736866 (1988-04-01), Leder et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4987071 (1991-01-01), Cech et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5116742 (1992-05-01), Cech et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5459039 (1995-10-01), Modrich et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
GenBank Accession No.: AAB00193 (Oct. 16, 2001).
GenBank Accession No.: AAB08543 (Sep. 20, 1996).
GenBank Accession No.: AAB08544 (Sep. 20, 1996).
GenBank Accession No.: AAB08547 (Sep. 20, 1996).
GenBank Accession No.: AAB12117 (Oct. 7, 1996).
GenBank Accession No.: AAB24422 (May 8, 1993).
GenBank Accession No.: AAB43987 (Feb. 7, 1997).
GenBank Accession No.: AAB48183 (Feb. 28, 1997).
GenBank Accession No.: AAB54035 (Nov. 19, 2002).
GenBank Accession No.: AAB54345 (May 14, 1997).
GenBank Accession No.: AAB55957 (May 14, 1997).
GenBank Accession No.: AAB59591 (Nov. 13, 1995).
GenBank Accession No.: AAB63531 (Jul. 21, 1997).
GenBank Accession No.: AAB63535 (Feb. 27, 2002).
GenBank Accession No.: AAB73307 (Oct. 8, 1997).
GenBank Accession No.: AAB73308 (Oct. 8, 1997).
GenBank Accession No.: AAB76853 (Oct. 8, 1997).
GenBank Accession No.: AAB81822 (Oct. 26, 1997).
GenBank Accession No.: AAB90773 (Mar. 17, 2003).
GenBank Accession No.: AAB96388 (Jul. 13, 2000).
GenBank Accession No.: AAE05921 (Sep. 29, 1999).
GenBank Accession No.: AAE06704 (Sep. 29, 1999).
GenBank Accession No.: AAG00220 (Aug. 16, 2000).
GenBank Accession No.: AAG10768 (Sep. 7, 2000).
GenBank Accession No.: AAG10769 (Sep. 7, 2000).
GenBank Accession No.: AAG10770 (Sep. 7, 2000).
GenBank Accession No.: AAM93539 (Jun. 30, 2003).
GenBank Accession No.: AAR26876 (Jan. 30, 2004).
GenBank Accession No.: AAR53992 (Dec. 16, 2003).
GenBank Accession No.: AAR91950 (Jan. 18, 2004).
GenBank Accession No.: AAR96044 (Jan. 21, 2004).
GenBank Accession No.: AAR96045 (Jan. 21, 2004).
GenBank Accession No.: AK005068 (Sep. 20, 2003).
GenBank Accession No.: AK021164 (Sep. 20, 2003).
GenBank Accession No.: AL033383 (Jun. 15, 2000).
GenBank Accession No.: BC002668 (Nov. 12, 2003).
GenBank Accession No.: BC012089 (Oct. 4, 2003).
GenBank Accession No.: L27124 (Sep. 30, 1994).
GenBank Accession No.: O43490 (Sep. 15, 2003).
GenBank Accession No.: P15541 (Mar. 15, 2004).
GenBank Accession No.: Q9W742 (Sep. 15, 2003).
GenBank Accession No.: S66253 (Mar. 13, 1997).
GenBank Accession No.: XM—008313 (May 8, 2002).
Albrecht, C., H. von Der Kammer, et al. (2000). “Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61.” J Biol Chem 275(37): 28929-36.
Brown, G. K. (2000). “Glucose transporters: structure, function and consequences of deficiency.” J Inherit Metab Dis 23(3): 237-46.
Drobnik, W., H. Borsukova, et al. (2002). “Apo Al/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based mircodomains.” Traffic 3(4): 268-78.
Hassan, R., J. L. Viner, et al. (2000). “Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma.” J Immunother 23(4): 473-9.
Hoover-Plow, J. and L. Yuen (2001). “Plasminogen binding is increased with adipocyte differentiation,” Biochem Biophys Res Commun 284(2): 389-94.
Hospital, V., V. Chesneau, et al. (2000). “N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface.” Biochem J 349(Pt 2): 587-97
Magee, J. A., T. Araki, et al. (2000). “Expression profiling reveals hepsin overexpression in prostate cancer.” Cancer Res 61(15): 5692-6
Moriwaki, J., E. Kajita, et al. (2000). “Isolation of Xenopus frizzled-10A and frizzled-10B genomic clones and their expression in adult tissues and embryos.” Biochem Biophys Res Commun 278(2): 377-84.
Nishi, E., A. Prat, et al. (2002). “N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration,” Embo J 20(13): 3342-50.
Ohkuma, S., M. Katsura, et al. (2001). “Alterations in cerebral diazeparn binding inhibitor expression in drug dependence: a possible biochemical alteration common to drug dependence.” Life Sci 68(11): 1215-22.
Selvarajan, S., L. R. Lund, et al. (2001). “A plasma kallikrien-dependent plasminogen cascade required for adipocyte differentiation.” Nat Cell Biol 3(3): 267-75.
Sonneveld, P. (2000). “Multidrug resistance in haematological malignancies.” J Intern Med 247(5): 521-34.
Takahashi, H., M. Oh-Ishi, et al. (2001) “Detection and identification of subcutaneous adipose tissue protein related to obesity in New Zealand obese mouse.” Endocr J 48(2): 205-11.
Takeda, A. (2000). “Movement of zinc and its functional significance in the brain.” Brain Res Brain Res Rev 34(3): 137-48.
Tang, X. and N. F. Shay (2001). “Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes.” J Nutr 131(5): 1414-20.
Tani, K., F. Ogushi, et al. (2001). “Protease-induced leukocyte chamotaxis and activation: roles in host defense and inflammation,” J Med Invest 48(3-4): 133-41.
Taupin, D., J. Pedersen, et al. (2001). “Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium.” Lab invest 81(3): 397-408.
Taylor, K. M. (2000). “LIV-1 breast cancer protein belongs to new family of histidine-rich membrane proteins with potential to control intracellular Zn2+ Homeostasis.” IUBMB Life 49(4): 249-53.
Wilkman, D , published by The Scientist, Inc., Philadelphia PA, vol. 14, No. 8 (Apr. 17, 2000), pp. 25-28.
Van Raay, T. J., Y. K. Wang, et al. (2001). “trizzled 9 is expressed in neural precursor cells in the developing neural tube.” Dev Genes Evol. 211(8-9): 453-7.
Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G., et al. (2001). “Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.” Neurobiol Aging 22(4):547-53.
Wu, Q. (2001). “Gene targeting in homostasis. Hepsin,” Front Biosci 6: D192-200.
Yousef, G. M. and E. P. Diamandis (2001). “The new human tissue kallikrein gene family: structure, function, and association to disease.” Endocr Rev 2

Affiliated with

Also associated with

Rating

Proteins and nucleic acids encoding same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Proteins and nucleic acids encoding same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins and nucleic acids encoding same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3668651